Persistent Hepatic Structural Alterations Following Nanoceria Vascular Infusion in the Rat

Toxicologic Pathology

Volumn 42, Issue 6, 2014, Pages 984-996

  Tseng, Michael T ^a   fu, Qiang ^b   Lor, Khoua ^c   Fernandez Botran, G Rafael ^a   Deng, Zhong Bin ^a   Graham, Uschi ^d   Butterfield, D Allan ^d   Grulke, Eric A ^e   Yokel, Robert A ^d  

^a University of Louisville School of Medicine   (United States)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^c UNIVERSITY OF LOUISVILLE   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

electron microscopy; histopathology; immunohistochemistry; liver; risk identification

Indexed keywords

CD3 ANTIGEN; CERIC OXIDE; CERIUM;

ANIMAL; APOPTOSIS; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; KUPFFER CELL; LIVER; MALE; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TUNEL ASSAY;

ANIMALS; ANTIGENS, CD3; APOPTOSIS; CELL PROLIFERATION; CERIUM; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; KUPFFER CELLS; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84905819963     PISSN: 01926233     EISSN: 15331601     Source Type: Journal    
DOI: 10.1177/0192623313505780     Document Type: Article

References (41)

1. Alexis F. Pridgen E. Molnar L. K. Farokhzad O. C. (2008). Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5, 505–15.
2. Bouwens L. Baekeland M. Wisse E. (1984). Importance of local proliferation in the expanding Kupffer cell population of rat liver after zymosan stimulation and partial hepatectomy. Hepatology 4, 213–9.
3. Cassee F. R. van Balen E. C. Singh C. Green D. Muijser H. Weinstein J. Dreher K. (2011). Exposure, health and ecological effects review of engineered nanoscale cerium and cerium oxide associated with its use as a fuel additive. Crit Rev Toxicol 41, 213–29.
4. Cheng S. H. Li F. C. Souris J. S. Yang C. S. Tseng F. G. Lee H. S. Chen C. T. Dong C. Y. Lo L. W. (2012). Visualizing dynamics of sub-hepatic distribution of nanoparticles using intravital multiphoton fluorescence microscopy. ACS Nano 22, 4122–31.
5. Cho W. S. Cho M. Jeong J. Choi M. Cho H. Y. Han B. S. Kim S. H. Kim H. O. Lim Y. T. Chung B. H. Jeong J (2009). Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol Appl Pharmacol 236, 16–24.
6. Cho W. S. Duffin R. Howie S. E. Scotton C. J. Wallace W. A. MacNee W. Bradley M. Megson I. L. Donaldson K. (2011). Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol 8, 27.
7. Co D. O. Hogan L. H. Kim S. I. Sandor M. (2004) Mycobacterial granulomas: Keys to a long-lasting host-pathogen relationship. Clin Immunol 113, 130–6.
8. Dan M. Wu P. Grulke E. A. Graham U. M. Unrine J. M. Yokel R. A. (2012). Ceria-engineered nanomaterial distribution in, and clearance from, blood: Size matters. Nanomedicine (Lond) 7, 95–110.
9. Gao B. (2012). Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease. J Gastroenterol Hepatol 2, 89–93.
10. George S. Lin S. Ji Z. Thomas C. R. Li L. Mecklenburg M. Meng H. Wang X. Zhang H. Xia T. Hohman J. N. Lin S. Zink J. I. Weiss P. S. Nel A. E. (2012). Surface defects on plate-shaped silver nanoparticles contribute to its hazard potential in a fish gill cell line and zebrafish embryos. ACS Nano 6, 3745–59.
11. Goodman J. E. Prueitt R. L. Thakali S. Oller A. R. (2011). The nickel ion bioavailability model of the carcinogenic potential of nickel-containing substances in the lung. Crit Rev Toxicol 41, 142–74.
12. Ji Z. Wang X. Zhang H. Lin S. Meng H. Sun B. George S. Xia T. Nel A. E. Zink J. I. (2012). Designed synthesis of CeO2 nanorods and nanowires for studying toxicological effects of high aspect ratio nanomaterials. ACS Nano 6, 5388–80.
13. Kumar V. Abbas A. Fausto N. Mitchell R. eds. (2007). Robbins Basic Pathology, 8th ed., pp. 56–57. Saunders Elsevier, Philadelphia, PA.
14. Kuschner W. G. D’Alessandro A. Wintermeyer S. F. Wong H. Boushey H. A. Blanc P. D. (1995). Pulmonary responses to purified zinc oxide fume. J Investig Med 43, 371–8.
15. Lankveld D. P. Oomen A. G. Krystek P. Neigh A. Troost-de Jong A. Noorlander C. W. Van Eijkeren J. C. Geertsma R. E. De Jong W. H. (2010). The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 31, 8350–61.
16. Lenaerts V. Nagelkerke J. F. Van Berkel T. J. Couvreur P. Grislain L. Roland M. Speiser P. (1984). In vivo uptake of polyisobutyl cyanoacrylate nanoparticles by rat liver Kupffer, endothelial, and parenchymal cells. J Pharm Sci 73, 980–82.
17. Liu T. Li L. Teng X. Huang X. Liu H. Chen D. Ren J. He J. Tang F. (2011). Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 32, 1657–68.
18. Liu T. Li L. Fu C. Liu H. Chen D. Tang F. (2012). Pathological mechanisms of liver injury caused by continuous intraperitoneal injection of silica nanoparticles. Biomaterials 33, 2399–407.
19. Mai H. X. Sun L. D. Zhang Y. W. Si R. Feng W. Zhang H. P. Liu H. C. Yan C. H. (2005). Shape-selective synthesis and oxygen storage behavior of ceria nanopolyhedra, nanorods, and nanocubes. J Phys Chem B 109, 24380–85.
20. Miyawaki J. Matsumura S. Yuge R. Murakami T. Sato S. Tomida A. Tsuruo T. Ischihashi T. Fujinami T. Irie H. Tsuchida K. Lijima S. Shiba K. Yudasaka M. (2009). Biodistribution and ultrastrucutral localization of single-walled carbon nanohorns determined in vivo with embedded Gd2O3 labels. ACS Nano 3, 1399–406.
21. Naito M. Hasegawa G. Takahashi K. (1997). Development, differentiation, and maturation of Kupffer cells. Microsc Res Tech 39, 350–64.
22. Nalabotu S. K. Kolli M. B. Triest W. E. Ma J. Y. Manne N. D. Katta A. Addagarla H. S. Rice K. M. Blough E. R. (2011). Intratracheal instillation of cerium oxide nanoparticles induces hepatic toxicity in male Sprague-Dawley rats. Int J Nanomed 6, 2327–35.
23. Nel A. Xia T. Madler L. Li N. (2006). Toxic potential of materials at the nanolevel. Science 311, 622–7.
24. Nishimori H. Kondoh M. Isoda K. Tsunoda S. Tsutsumi Y. Yagi K. (2009). Silica nanoparticles as hepatotoxicants. Eur J Pharm Biopharm 72, 496–501.
25. Pott F. Rippe R. Roller M. Csicsaky M. Rosenbruch M. Huth F. (1992). Carcinogenicity of nickel compounds and nickel alloys in rats by i.p. injection. In Nickel and Human Health: Current Perspectives (Nieboer E. Nriague J., eds.), pp. 491–502. John Wiley, New York, NY.
26. E.E.L., Rossi, A.J., Koivisto, M., Vippola, K.A., Jensen, M., Miettinen, K.H., Sirola, P., Karisola, T., Stjernvall, E., Vanhala, M., Kiilunen, P., Pasanen, M., Mäkinen, K., Hämeri, J., Joutsensaari, T., Tumoi, J., Jokiniemi, H., Wolff, K., Savolainen, S., Matikainen, H., Alenius, Airway exposure to silica-coated TiO2 nanoparticles induces pulmonary neutrophilia in mice, Toxicol Sci, (2010), 113, 422-433
27. Sadauskas E. Wallin H. Stoltenberg M. Vogel U. Doering P. Larsen A. Danscher G. (2007). Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 4, 10.
28. Schipper M. L. Iyer G. Koh A. L. Cheng Z. Ebenstein Y. Aharoni A. Keren S. Bentolila L. A. Li J. Rao J. Chen X. Banin U. Wu A. M. Sinclair R. Weiss S. Gambhir S. S. (2009). Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. Small 5, 126–34.
29. Schreiber H. A. Harding J. S. Hunt O. Altamirano C. J. Hulseberg P. D. Stewart D. Fabry Z. Sandor M. (2011). Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J Clin Invest 121, 3902–13.
30. Song Y. Tang S. (2011). Nanoexposure, unusual diseases, and new health and safety concerns. Scient World J 11, 1821–8.
31. Tsai C. Y. Lu S. I. Hu C. W. Yeh C. S. Lee G. B. Lei H. Y. (2012). Size-dependent attenuation of TLR9 signaling by gold nanoparticles in macrophages. J Immunol 188, 68–76.
32. Tseng M. T. Lu X. Duan X. Hardas S. S. Sultana R. Wu P. Unrine J. M. Graham U. Butterfield D. A. Grulke E. A. Yokel R. A. (2012). Alteration of hepatic structure and oxidative stress induced by intravenous nanoceria. Toxicol Appl Pharmacol 260, 173–82.
33. T., Ulrichs, S.S.E., Kaufmann, New insights into the function of granulomas in human tuberculosis, J Pathol, (2006), 208, 261-269
34. Winterstein J. P. Basu J. Herzing A. Anderson I. M. Carter C. (2008). Combined structural and chemical investigations of ceria nanoparticles in the TEM. Microsc Microanal 14, 280–81.
35. Wisse E. (1974). Kupffer cell reactions in rat liver under various conditions as observed in the electron microscope. J Ultrastruct Res 46, 499–520.
36. Xia T. Kovochich M. Liong M. Mädler L. Gilbert B. Shi H. Yeh J. I. Zink J. I. Nel A. E. (2008). Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2, 2121–34.
37. Xie G. Wang C. Sun J. Zhong G. (2011). Tissue distribution and excretion of intravenously administered titanium dioxide nanoparticles. Toxicol Lett 205, 55–61.
38. Yamada M. Naito M. Takahashi K. (1990). Kupffer cell proliferation and glucan-induced granuloma formation in mice depleted of blood monocytes by strontium-89. J Leukoc Biol 47, 195–205.
39. Yang S. T. Guo W. Lin Y. Deng X. Y. Wang H. F. Sun H. F. Liu Y. F. Wang X. Wang W. Chen M. Huang Y. P. Sun Y. P. (2007). Biodistribution of pristine single-walled carbon nanotubes in vivo. J Phys Chem C 111, 17761–4.
40. Yokel R. A. Florence R. L. Unrine J. M. Tseng M. T. Graham U. M. Wu P. Grulke E. A. Sultana R. Hardas S. S. Butterfield D. A. (2009). Biodistribution and oxidative stress effects of a systemically-introduced commercial ceria engineered nanomaterial. Nanotoxicology 3, 234–48.
41. Yokel R. A. Au T. C. MacPhail R. Hardas S. S. Butterfield D. A. Sultana R. Goodman M. Tseng M. T. Dan M. Haghnazar H. Unrine J. M. Graham U. M. Wu P. Grulke E. A. (2012). Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats. Toxicol Sci 127, 256–68.